J&J granted FDA nod for integrated catheter ablation solution
Seeking Alpha ·
Johnson & Johnson ( JNJ ) on Wednesday announced the FDA approval for a MedTech device designed to deliver both radiofrequency and pulsed field energy in a single integrated catheter for cardiac ablation procedures. The product, branded as the Dual Energy THERMOCOOL SMARTTOUCH
DYAX Investor Sentiment
Bullish (Long) 36% · Bearish (Short) 64%
407 participants
Related News
- Trump warns of imminent new strikes on Iran - report
- Immunome granted FDA review for tumor candidate
- ClearBridge Dividend Strategy adds Nvidia, TSM; exits UnitedHealth among Q2 moves
- Employment participation faces risk of a snapback as unemployment expected to rise in H2 – Pantheon Macroeconomics
- Stock Market Today: Dow Dives As Trump Declares Iran Ceasefire 'Over'; Micron, Sandisk Reverse (Live Coverage)
- AI bubble or not? SA analysts offer both perspectives as H2 2026 kicks off